NIRAPARIB

NIRAPARIB was reported 22176 times

NIRAPARIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CARBOHYDRATE ANTIGEN 125 INCREASED 1850 0.5419
1 COMPUTERISED TOMOGRAM PELVIS ABNORMAL 10 0.5263
2 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS 36 0.3871
3 CARBOHYDRATE ANTIGEN 125 10 0.3333
4 OVARIAN CANCER RECURRENT 498 0.3097
5 OVARIAN EPITHELIAL CANCER RECURRENT 11 0.2037
6 RECURRENT CANCER 774 0.1896
7 SCAN ABNORMAL 53 0.1436
8 DRUG MONITORING PROCEDURE NOT PERFORMED 257 0.1429
9 LYMPHANGIOLEIOMYOMATOSIS 15 0.1376
10 LIVER SCAN ABNORMAL 22 0.1350
11 POSITRON EMISSION TOMOGRAM ABNORMAL 85 0.1216
12 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 128 0.1027
13 CORONAVIRUS TEST POSITIVE 94 0.0913
14 INTENTIONAL UNDERDOSE 658 0.0900
15 OVARIAN CANCER METASTATIC 70 0.0824
16 COMPUTERISED TOMOGRAM ABNORMAL 180 0.0794
17 TUMOUR MARKER INCREASED 359 0.0747
18 MALIGNANT PERITONEAL NEOPLASM 43 0.0728
19 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 48 0.0724
20 FALLOPIAN TUBE CANCER 10 0.0694
21 OVARIAN CANCER 620 0.0672
22 FLUID REPLACEMENT 21 0.0621
23 TUMOUR MARKER ABNORMAL 20 0.0604
24 TUMOUR MARKER DECREASED 10 0.0559
25 DECREASED ACTIVITY 584 0.0541
26 CENTRAL VENOUS CATHETER REMOVAL 25 0.0533
27 RED BLOOD CELL COUNT DECREASED 1355 0.0473
28 PELVIC NEOPLASM 15 0.0434
29 WHITE COAT HYPERTENSION 23 0.0424
30 MEAN CELL VOLUME ABNORMAL 20 0.0424
31 OVARIAN CANCER STAGE III 14 0.0403
32 MEAN CELL HAEMOGLOBIN INCREASED 65 0.0392
33 PLATELET COUNT DECREASED 4145 0.0389
34 ABDOMINAL CAVITY DRAINAGE 16 0.0379
35 OVARIAN CANCER STAGE IV 15 0.0359
36 RED BLOOD CELL COUNT ABNORMAL 52 0.0354
37 MEAN CELL VOLUME INCREASED 90 0.0350
38 PLATELET DISORDER 82 0.0325
39 STOMA CLOSURE 10 0.0322
40 FULL BLOOD COUNT ABNORMAL 340 0.0321
41 NEUTROPHIL PERCENTAGE DECREASED 17 0.0319
42 URETERAL STENT INSERTION 11 0.0315
43 ABDOMINAL NEOPLASM 27 0.0302
44 COLOSTOMY CLOSURE 10 0.0292
45 BLOOD MAGNESIUM DECREASED 251 0.0291
46 BLOOD COUNT ABNORMAL 429 0.0283
47 CORONAVIRUS INFECTION 183 0.0276
48 PRODUCT MONITORING ERROR 38 0.0263
49 PELVIC MASS 21 0.0260
50 DRAINAGE 12 0.0243
51 METASTASES TO SPLEEN 10 0.0242
52 METASTASES TO PELVIS 15 0.0237
53 METASTASES TO ABDOMINAL CAVITY 11 0.0224
54 PHOTOSENSITIVITY REACTION 364 0.0220
55 RED BLOOD CELL ABNORMALITY 21 0.0219
56 RED CELL DISTRIBUTION WIDTH INCREASED 88 0.0212
57 ASPIRATION PLEURAL CAVITY 16 0.0208
58 BLOOD CREATINE ABNORMAL 10 0.0207
59 HAEMATOCRIT DECREASED 404 0.0204
60 HERNIA PAIN 9 0.0196
61 MEAN PLATELET VOLUME DECREASED 16 0.0191
62 NEOPLASM RECURRENCE 64 0.0189
63 CONSTIPATION 4108 0.0188
64 BLAST CELLS PRESENT 9 0.0187
65 PERITONEAL DISORDER 12 0.0185
66 PLATELET COUNT ABNORMAL 112 0.0185
67 LABORATORY TEST ABNORMAL 532 0.0180
68 FAECES HARD 69 0.0177
69 MASTECTOMY 31 0.0177
70 HERNIA REPAIR 46 0.0177
71 FULL BLOOD COUNT DECREASED 352 0.0175
72 METASTASES TO PERITONEUM 44 0.0174
73 COLOSTOMY 34 0.0173
74 HAEMOGLOBIN DECREASED 1753 0.0171
75 MALIGNANT ASCITES 13 0.0169
76 BLOOD TEST ABNORMAL 236 0.0168
77 BLOOD PRESSURE INCREASED 2458 0.0161
78 PERFORMANCE STATUS DECREASED 72 0.0154
79 PETECHIAE 160 0.0153
80 INCISIONAL HERNIA 21 0.0151
81 PRODUCT DOSE OMISSION IN ERROR 428 0.0151
82 RENAL FUNCTION TEST ABNORMAL 70 0.0151
83 HEPATIC MASS 29 0.0150
84 PARACENTESIS 9 0.0146
85 TASTE DISORDER 293 0.0144
86 BLOOD MAGNESIUM INCREASED 13 0.0144
87 SOCIAL PROBLEM 59 0.0142
88 FLUID INTAKE REDUCED 71 0.0142
89 TUMOUR EXCISION 11 0.0137
90 NEAR DEATH EXPERIENCE 45 0.0136
91 CATHETER MANAGEMENT 12 0.0133
92 MALIGNANT NEOPLASM PROGRESSION 1357 0.0132
93 WHITE BLOOD CELL COUNT DECREASED 1413 0.0130
94 PELVIC DISCOMFORT 12 0.0127
95 ABDOMINAL LYMPHADENOPATHY 11 0.0127
96 HOSPICE CARE 125 0.0126
97 BLOOD PRESSURE DIASTOLIC INCREASED 58 0.0126
98 TRANSFUSION REACTION 11 0.0125
99 PLATELET TRANSFUSION 16 0.0124
100 HEART RATE INCREASED 1231 0.0124
101 THYROID HORMONES INCREASED 13 0.0124
102 ENERGY INCREASED 73 0.0124
103 COLONOSCOPY 26 0.0118
104 FOOD AVERSION 20 0.0118
105 APPETITE DISORDER 78 0.0118
106 BLOOD PRESSURE FLUCTUATION 282 0.0117
107 BLOOD UREA ABNORMAL 11 0.0117
108 NEUROPATHY PERIPHERAL 1109 0.0116
109 ABDOMINAL MASS 31 0.0116
110 THYROID HORMONES DECREASED 9 0.0112
111 BONE MARROW DISORDER 34 0.0112
112 MYELODYSPLASTIC SYNDROME 162 0.0112
113 LARGE INTESTINAL OBSTRUCTION 25 0.0112
114 INTRA-ABDOMINAL FLUID COLLECTION 20 0.0112
115 HEPATIC NEOPLASM 36 0.0110
116 SUNBURN 82 0.0110
117 MEAN CELL HAEMOGLOBIN DECREASED 20 0.0109
118 MIDDLE INSOMNIA 204 0.0109
119 REFLUX GASTRITIS 13 0.0108
120 BIOPSY 10 0.0108
121 ABDOMINAL HERNIA 49 0.0107
122 INSOMNIA 2844 0.0107
123 HEPATIC LESION 46 0.0106
124 PHARYNGEAL HAEMORRHAGE 13 0.0106
125 DRY MOUTH 852 0.0105
126 RETCHING 223 0.0104
127 CANCER SURGERY 10 0.0104
128 HAEMOGLOBIN ABNORMAL 67 0.0104
129 GLOMERULAR FILTRATION RATE DECREASED 126 0.0102
130 TRANSFUSION 107 0.0102
131 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 17 0.0102
132 METASTASES TO LYMPH NODES 68 0.0101
133 MAGNETIC RESONANCE IMAGING ABNORMAL 12 0.0100
134 NEUTROPHIL COUNT DECREASED 406 0.0100
135 BLOOD CREATINE INCREASED 44 0.0099
136 MILIARIA 17 0.0099
137 PHARYNGEAL ULCERATION 13 0.0098
138 GASTROINTESTINAL MOTILITY DISORDER 52 0.0097
139 THROMBOCYTOPENIA 1076 0.0096
140 INTESTINAL OBSTRUCTION 362 0.0096
141 BLOOD CREATININE ABNORMAL 33 0.0095
142 RED BLOOD CELL COUNT INCREASED 26 0.0094
143 HAIR GROWTH ABNORMAL 65 0.0094
144 MOTION SICKNESS 18 0.0093
145 BLOOD CREATININE DECREASED 29 0.0093
146 INITIAL INSOMNIA 95 0.0092
147 NAIL GROWTH ABNORMAL 10 0.0091
148 ADVERSE DRUG REACTION 810 0.0090
149 MONOCYTE COUNT DECREASED 11 0.0090
150 ILEOSTOMY 23 0.0090
151 STENT PLACEMENT 72 0.0089
152 BOWEL MOVEMENT IRREGULARITY 67 0.0087
153 GASTROINTESTINAL WALL THICKENING 13 0.0087
154 BLOOD POTASSIUM DECREASED 260 0.0086
155 THYROID MASS 33 0.0086
156 STOMATITIS 518 0.0085
157 SLEEP DISORDER 600 0.0085
158 NODULE 110 0.0084
159 TUMOUR PAIN 11 0.0083
160 BLOOD CREATININE INCREASED 541 0.0083
161 GASTROINTESTINAL STOMA COMPLICATION 13 0.0083
162 RENAL IMPAIRMENT 695 0.0083
163 ORAL PAIN 184 0.0082
164 ACUTE MYELOID LEUKAEMIA 128 0.0082
165 UPPER-AIRWAY COUGH SYNDROME 67 0.0081
166 DECREASED APPETITE 1884 0.0081
167 CARDIAC FLUTTER 52 0.0080
168 WHITE BLOOD CELL COUNT ABNORMAL 51 0.0080
169 TERMINAL INSOMNIA 14 0.0079
170 BLOOD PRESSURE ABNORMAL 157 0.0079
171 WHITE BLOOD CELL DISORDER 21 0.0078
172 CHANGE OF BOWEL HABIT 16 0.0078
173 GINGIVAL BLEEDING 106 0.0078
174 ASCITES 228 0.0077
175 ANAEMIA 1472 0.0077
176 NAIL DISCOLOURATION 30 0.0076
177 BLOOD IRON DECREASED 90 0.0076
178 METASTASIS 54 0.0076
179 BLOOD IRON INCREASED 14 0.0075
180 SMALL INTESTINAL OBSTRUCTION 91 0.0074
181 ERUCTATION 143 0.0074
182 DISEASE PROGRESSION 874 0.0074
183 BLOOD SODIUM DECREASED 139 0.0074
184 NAUSEA 5789 0.0073
185 VITAMIN B12 DECREASED 21 0.0073
186 INFREQUENT BOWEL MOVEMENTS 18 0.0072
187 EARLY SATIETY 14 0.0072
188 INCREASED TENDENCY TO BRUISE 66 0.0072
189 HERNIA 138 0.0071
190 MEAN CELL VOLUME DECREASED 11 0.0071
191 NEOPLASM PROGRESSION 247 0.0071
192 LYMPHOEDEMA 49 0.0071
193 DENTAL CARE 13 0.0070
194 BLOOD CHLORIDE DECREASED 18 0.0070
195 DYSPNOEA EXERTIONAL 262 0.0069
196 ABDOMINAL OPERATION 9 0.0069
197 TONGUE DISCOMFORT 29 0.0068
198 HAEMATOTOXICITY 64 0.0067
199 FATIGUE 5237 0.0067
200 NEUTROPHIL COUNT ABNORMAL 19 0.0067
201 CARCINOEMBRYONIC ANTIGEN INCREASED 13 0.0067
202 POOR QUALITY SLEEP 143 0.0066
203 HEART RATE ABNORMAL 37 0.0066
204 PROTEIN URINE PRESENT 33 0.0066
205 NEOPLASM 76 0.0066
206 GASTRIC INFECTION 25 0.0065
207 MALIGNANT PLEURAL EFFUSION 11 0.0065
208 BRAIN FOG 101 0.0064
209 PARANASAL SINUS DISCOMFORT 24 0.0063
210 BLOOD ELECTROLYTES DECREASED 9 0.0063
211 PULMONARY MASS 94 0.0063
212 PRODUCT DOSE OMISSION ISSUE 1855 0.0063
213 LIP PAIN 18 0.0063
214 DYSPEPSIA 615 0.0062
215 MULTIPLE ALLERGIES 49 0.0062
216 BLOOD UREA INCREASED 104 0.0062
217 HYPERTENSION 1313 0.0062
218 PIGMENTATION DISORDER 38 0.0061
219 BLOOD BLISTER 19 0.0061
220 ADHESION 9 0.0060
221 ENDODONTIC PROCEDURE 15 0.0059
222 TRIGGER FINGER 24 0.0059
223 FLATULENCE 332 0.0058
224 VITAMIN D DECREASED 50 0.0058
225 LYMPHOCYTE COUNT INCREASED 19 0.0058
226 FEEDING DISORDER 117 0.0058
227 BLOOD PRESSURE SYSTOLIC INCREASED 111 0.0057
228 LYMPHADENOPATHY 199 0.0056
229 URINE ODOUR ABNORMAL 33 0.0056
230 ABDOMINAL RIGIDITY 15 0.0055
231 DRY THROAT 56 0.0055
232 PALPITATIONS 644 0.0055
233 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 264 0.0055
234 CONTUSION 529 0.0055
235 TONGUE DISCOLOURATION 24 0.0055
236 VOLVULUS 13 0.0055
237 TACHYPHRENIA 19 0.0055
238 MOUTH HAEMORRHAGE 40 0.0055
239 ILEUS 67 0.0054
240 TONGUE BLISTERING 12 0.0054
241 HAEMORRHAGE SUBCUTANEOUS 19 0.0054
242 EMERGENCY CARE 16 0.0053
243 DENTAL OPERATION 13 0.0053
244 MONOCYTE COUNT INCREASED 19 0.0052
245 ANAEMIA MACROCYTIC 11 0.0051
246 ORAL SURGERY 12 0.0051
247 METASTASES TO LIVER 90 0.0051
248 ABDOMINAL DISCOMFORT 855 0.0051
249 CANCER PAIN 13 0.0051
250 NAIL DISORDER 44 0.0050
251 HOT FLUSH 379 0.0050
252 PLATELET COUNT INCREASED 65 0.0050
253 SEASONAL ALLERGY 70 0.0049
254 ASTHENIA 1858 0.0049
255 ONYCHOCLASIS 34 0.0049
256 ANIMAL BITE 13 0.0049
257 HEART RATE IRREGULAR 110 0.0049
258 RENAL MASS 10 0.0048
259 UNDERDOSE 353 0.0048
260 BLADDER SPASM 9 0.0048
261 METASTASES TO CENTRAL NERVOUS SYSTEM 62 0.0048
262 MASS 67 0.0048
263 BLOOD CALCIUM INCREASED 42 0.0048
264 NOCTURIA 58 0.0048
265 TEMPERATURE INTOLERANCE 49 0.0047
266 TOOTH EXTRACTION 59 0.0047
267 MENOPAUSAL SYMPTOMS 11 0.0047
268 ABDOMINAL DISTENSION 493 0.0047
269 LYMPHADENOPATHY MEDIASTINAL 9 0.0047
270 MACULE 13 0.0047
271 SPONDYLITIS 17 0.0047
272 INGROWING NAIL 11 0.0047
273 DIZZINESS POSTURAL 45 0.0046
274 PAROSMIA 35 0.0046
275 PRODUCT DOSE OMISSION 301 0.0046
276 BONE PAIN 270 0.0046
277 SINUS DISORDER 91 0.0046
278 ILLNESS 473 0.0046
279 THIRST 82 0.0046
280 SURGERY 268 0.0046
281 FAECALOMA 25 0.0046
282 BRAIN NEOPLASM 41 0.0045
283 ABDOMINAL ADHESIONS 14 0.0044
284 HAEMOGLOBIN INCREASED 20 0.0044
285 DEHYDRATION 584 0.0044
286 BLOOD DISORDER 35 0.0044
287 VOMITING 2037 0.0043
288 ILL-DEFINED DISORDER 262 0.0043
289 HYDRONEPHROSIS 32 0.0043
290 HOSPITALISATION 656 0.0043
291 MUSCLE FATIGUE 18 0.0042
292 AGEUSIA 106 0.0042
293 RENAL NEOPLASM 9 0.0042
294 GASTROINTESTINAL SOUNDS ABNORMAL 21 0.0042
295 HEPATIC ENZYME ABNORMAL 21 0.0042
296 FEELING JITTERY 80 0.0042
297 SINUS OPERATION 10 0.0042
298 BALANCE DISORDER 361 0.0042
299 LUNG OPACITY 11 0.0042
300 GASTROINTESTINAL OBSTRUCTION 10 0.0041
301 ABDOMINAL PAIN UPPER 855 0.0041
302 NASAL DRYNESS 26 0.0041
303 GINGIVAL PAIN 33 0.0041
304 TONGUE ULCERATION 14 0.0041
305 RENAL DISORDER 192 0.0041
306 CYTOPENIA 50 0.0041
307 CATARACT OPERATION 24 0.0040
308 URINE ANALYSIS ABNORMAL 12 0.0040
309 MUSCULOSKELETAL DISCOMFORT 69 0.0040
310 BLOOD POTASSIUM INCREASED 65 0.0040
311 DYSGEUSIA 295 0.0040
312 FRUSTRATION TOLERANCE DECREASED 32 0.0040
313 URINE ABNORMALITY 18 0.0040
314 BRAIN OPERATION 9 0.0039
315 METASTATIC NEOPLASM 17 0.0039
316 SARS-COV-2 TEST POSITIVE 52 0.0039
317 DYSCHEZIA 12 0.0039
318 MUSCLE STRAIN 34 0.0039
319 EATING DISORDER 83 0.0039
320 SINUS PAIN 9 0.0039
321 PULMONARY THROMBOSIS 42 0.0038
322 HEAD DISCOMFORT 68 0.0038
323 FOOD INTOLERANCE 14 0.0038
324 SENSITIVE SKIN 28 0.0038
325 RESTLESS LEGS SYNDROME 69 0.0038
326 PANCYTOPENIA 212 0.0038
327 HEADACHE 2372 0.0038
328 PROTEIN TOTAL INCREASED 10 0.0038
329 BONE MARROW FAILURE 76 0.0037
330 FOOD POISONING 20 0.0037
331 CHAPPED LIPS 16 0.0037
332 DRUG INTOLERANCE 354 0.0037
333 OROPHARYNGEAL DISCOMFORT 33 0.0036
334 SCIATICA 58 0.0036
335 GASTROINTESTINAL PAIN 40 0.0036
336 BLOOD URINE PRESENT 69 0.0036
337 NEURALGIA 88 0.0036
338 BACK PAIN 837 0.0036
339 OROPHARYNGEAL PAIN 333 0.0036
340 EPIGASTRIC DISCOMFORT 14 0.0036
341 PERIPHERAL COLDNESS 49 0.0036
342 THYROID DISORDER 55 0.0036
343 RHINORRHOEA 228 0.0035
344 EMOTIONAL DISTRESS 427 0.0035
345 BRUXISM 19 0.0035
346 LIMB DISCOMFORT 109 0.0035
347 OESOPHAGEAL STENOSIS 10 0.0035
348 GASTROOESOPHAGEAL REFLUX DISEASE 283 0.0035
349 APHTHOUS ULCER 27 0.0035
350 ABDOMINAL PAIN LOWER 88 0.0035
351 NIGHT SWEATS 112 0.0035
352 EPISTAXIS 260 0.0035
353 BLOOD ALKALINE PHOSPHATASE INCREASED 86 0.0035
354 METASTASES TO LUNG 40 0.0035
355 BLOOD CHOLESTEROL INCREASED 160 0.0034
356 PARANASAL SINUS HYPERSECRETION 13 0.0034
357 FEELING ABNORMAL 807 0.0034
358 SINUS HEADACHE 20 0.0034
359 LYMPHOCYTE COUNT DECREASED 59 0.0033
360 WALKING AID USER 22 0.0033
361 URINARY TRACT INFECTION 567 0.0033
362 GASTROENTERITIS VIRAL 60 0.0033
363 MYALGIA 564 0.0033
364 WEIGHT DECREASED 924 0.0033
365 PRODUCT USE COMPLAINT 52 0.0033
366 MUSCULOSKELETAL CHEST PAIN 51 0.0033
367 DISEASE COMPLICATION 15 0.0033
368 OBSTRUCTION 13 0.0033
369 SKIN DISCOLOURATION 149 0.0032
370 ABDOMINAL TENDERNESS 16 0.0032
371 DIZZINESS 1603 0.0032
372 GLUCOSE TOLERANCE IMPAIRED 19 0.0032
373 REGURGITATION 11 0.0032
374 NERVOUSNESS 167 0.0032
375 MICTURITION DISORDER 11 0.0032
376 GINGIVAL SWELLING 14 0.0032
377 ORAL DISORDER 23 0.0031
378 THYROID FUNCTION TEST ABNORMAL 13 0.0031
379 UPPER RESPIRATORY TRACT CONGESTION 9 0.0031
380 LOOSE TOOTH 10 0.0031
381 ARTHROPOD BITE 23 0.0031
382 GLOSSITIS 11 0.0031
383 FLANK PAIN 29 0.0031
384 MYELOSUPPRESSION 111 0.0031
385 ORAL INFECTION 12 0.0031
386 ECCHYMOSIS 21 0.0031
387 ANXIETY 871 0.0031
388 INTENTIONAL DOSE OMISSION 87 0.0030
389 FOOD CRAVING 16 0.0030
390 SLUGGISHNESS 31 0.0030
391 SECRETION DISCHARGE 38 0.0030
392 NERVE COMPRESSION 28 0.0030
393 FAECES SOFT 22 0.0030
394 TENSION HEADACHE 13 0.0030
395 TEARFULNESS 13 0.0030
396 ORAL DISCOMFORT 42 0.0030
397 HYPERPHAGIA 12 0.0030
398 CENTRAL VENOUS CATHETERISATION 9 0.0030
399 PAPULE 21 0.0030
400 POSTOPERATIVE WOUND INFECTION 20 0.0030
401 ABDOMINAL PAIN 688 0.0030
402 ARTHRALGIA 1221 0.0029
403 FAMILY STRESS 9 0.0029
404 FUNCTIONAL GASTROINTESTINAL DISORDER 10 0.0029
405 PSYCHOMOTOR HYPERACTIVITY 48 0.0029
406 TOOTH INFECTION 38 0.0029
407 FORMICATION 20 0.0029
408 LIP DRY 26 0.0029
409 ODYNOPHAGIA 17 0.0028
410 MADAROSIS 33 0.0028
411 BREAST MASS 19 0.0028
412 PELVIC PAIN 51 0.0028
413 ELECTROCARDIOGRAM ABNORMAL 22 0.0028
414 APPENDICECTOMY 10 0.0028
415 SALIVARY HYPERSECRETION 28 0.0028
416 NASAL CONGESTION 164 0.0028
417 OESOPHAGEAL PAIN 11 0.0028
418 COGNITIVE DISORDER 130 0.0028
419 HORDEOLUM 12 0.0028
420 DYSPHONIA 162 0.0028
421 GLOSSODYNIA 62 0.0028
422 ONYCHOMYCOSIS 12 0.0027
423 SUPRAVENTRICULAR TACHYCARDIA 26 0.0027
424 COUGH 761 0.0027
425 DYSPHAGIA 256 0.0027
426 THERAPY CESSATION 138 0.0027
427 ABNORMAL FAECES 22 0.0027
428 EAR PAIN 52 0.0027
429 PHARYNGEAL SWELLING 26 0.0027
430 HUNGER 37 0.0027
431 HEPATIC CYST 9 0.0026
432 ARTHRITIS 208 0.0026
433 MUCOSAL INFLAMMATION 69 0.0026
434 DYSURIA 97 0.0026
435 TONGUE DISORDER 19 0.0026
436 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 473 0.0026
437 ONYCHOMADESIS 11 0.0026
438 POLLAKIURIA 108 0.0026
439 CYSTITIS 82 0.0026
440 OFF LABEL USE 2250 0.0026
441 UMBILICAL HERNIA 12 0.0026
442 MUSCLE SPASMS 469 0.0026
443 MEMORY IMPAIRMENT 350 0.0025
444 RENAL PAIN 27 0.0025
445 NECK PAIN 142 0.0025
446 HYSTERECTOMY 22 0.0025
447 DYSPNOEA 1436 0.0025
448 HYPOAESTHESIA 379 0.0025
449 FIBRIN D DIMER INCREASED 9 0.0025
450 BREAST PAIN 27 0.0025
451 EMOTIONAL DISORDER 78 0.0025
452 HAEMORRHAGIC DIATHESIS 9 0.0025
453 INCREASED APPETITE 48 0.0025
454 PERIPHERAL SWELLING 387 0.0025
455 HAEMORRHOIDS 49 0.0025
456 FAILURE TO THRIVE 13 0.0025
457 KIDNEY INFECTION 49 0.0025
458 TENDERNESS 26 0.0025
459 BLOOD CALCIUM DECREASED 28 0.0025
460 PROCTALGIA 16 0.0025
461 NASOPHARYNGITIS 458 0.0025
462 THERAPEUTIC RESPONSE UNEXPECTED 111 0.0025
463 RESPIRATION ABNORMAL 17 0.0025
464 SERUM FERRITIN INCREASED 13 0.0025
465 MALAISE 1080 0.0025
466 VITREOUS FLOATERS 24 0.0024
467 KNEE OPERATION 24 0.0024
468 CYST 30 0.0024
469 PLEURAL EFFUSION 147 0.0024
470 PRODUCTIVE COUGH 115 0.0024
471 PULMONARY TOXICITY 17 0.0024
472 SKIN DISORDER 80 0.0024
473 HIATUS HERNIA 31 0.0024
474 PROTEIN TOTAL DECREASED 9 0.0024
475 EYE OPERATION 11 0.0024
476 MUSCULAR WEAKNESS 270 0.0024
477 LIVER FUNCTION TEST INCREASED 51 0.0024
478 HYPERSOMNIA 68 0.0024
479 PAIN IN EXTREMITY 698 0.0024
480 GAIT INABILITY 79 0.0024
481 HYPERKERATOSIS 13 0.0024
482 HEPATIC ENZYME INCREASED 160 0.0023
483 HEPATIC PAIN 10 0.0023
484 GINGIVAL DISORDER 9 0.0023
485 THERAPY CHANGE 23 0.0023
486 EAR DISCOMFORT 24 0.0023
487 OESOPHAGEAL DISORDER 9 0.0023
488 HYPERTENSIVE CRISIS 26 0.0023
489 SKIN ABRASION 11 0.0023
490 CANDIDA INFECTION 39 0.0023
491 TACHYCARDIA 205 0.0023
492 EXTRASYSTOLES 16 0.0023
493 SKIN ODOUR ABNORMAL 9 0.0023
494 CONDITION AGGRAVATED 686 0.0023
495 ENTEROCOLITIS 13 0.0022
496 TERMINAL STATE 15 0.0022
497 INTRACRANIAL ANEURYSM 9 0.0022
498 LEUKAEMIA 21 0.0022
499 THROMBOSIS 179 0.0022
500 GINGIVITIS 12 0.0022
501 GALLBLADDER OPERATION 9 0.0022
502 VITAMIN B12 DEFICIENCY 9 0.0022
503 FEELING OF BODY TEMPERATURE CHANGE 13 0.0022
504 HIP SURGERY 12 0.0022
505 TOOTHACHE 40 0.0022
506 HYPERCHLORHYDRIA 13 0.0022
507 HICCUPS 18 0.0022
508 EXOSTOSIS 20 0.0022
509 FEELING HOT 134 0.0022
510 EAR DISORDER 10 0.0022
511 HYPERHIDROSIS 280 0.0022
512 BLOOD CHOLESTEROL ABNORMAL 10 0.0022
513 GROIN PAIN 19 0.0022
514 PRODUCT USE IN UNAPPROVED INDICATION 536 0.0022
515 FEELING COLD 60 0.0022
516 PURPURA 19 0.0021
517 SINUS CONGESTION 29 0.0021
518 INCREASED UPPER AIRWAY SECRETION 11 0.0021
519 SENSATION OF FOREIGN BODY 18 0.0021
520 JOINT STIFFNESS 56 0.0021
521 GASTRITIS 56 0.0021
522 SKIN LACERATION 23 0.0021
523 TOOTH DISORDER 47 0.0021
524 APLASTIC ANAEMIA 11 0.0021
525 SNEEZING 47 0.0021
526 CRYING 76 0.0021
527 BACK DISORDER 34 0.0021
528 HIP ARTHROPLASTY 32 0.0021
529 CHROMATURIA 47 0.0021
530 GASTROINTESTINAL TOXICITY 10 0.0021
531 ANORECTAL DISCOMFORT 11 0.0021
532 LOW DENSITY LIPOPROTEIN INCREASED 16 0.0021
533 MELANOCYTIC NAEVUS 9 0.0021
534 EMBOLISM 17 0.0020
535 INTESTINAL RESECTION 11 0.0020
536 WHEELCHAIR USER 9 0.0020
537 LIGAMENT SPRAIN 20 0.0020
538 NASAL DISCOMFORT 16 0.0020
539 RENAL CYST 16 0.0020
540 MICTURITION URGENCY 23 0.0020
541 BLOOD GLUCOSE INCREASED 378 0.0020
542 TINNITUS 92 0.0020
543 TENDONITIS 31 0.0020
544 ASTHENOPIA 11 0.0020
545 TREMOR 332 0.0020
546 GLYCOSYLATED HAEMOGLOBIN INCREASED 50 0.0020
547 OSTEOPENIA 30 0.0020
548 RASH PRURITIC 107 0.0020
549 IMMUNE SYSTEM DISORDER 26 0.0020
550 JOINT INJURY 42 0.0020
551 TOOTH ABSCESS 20 0.0020
552 ADVERSE REACTION 26 0.0020
553 BLOOD THYROID STIMULATING HORMONE INCREASED 18 0.0020
554 HERPES ZOSTER 112 0.0019
555 URINE OUTPUT DECREASED 17 0.0019
556 GASTROINTESTINAL DISORDER 173 0.0019
557 CATARACT 115 0.0019
558 WHITE BLOOD CELL COUNT INCREASED 74 0.0019
559 CARDIAC VALVE DISEASE 11 0.0019
560 DRY EYE 96 0.0019
561 ABNORMAL DREAMS 53 0.0019
562 BLOOD GLUCOSE FLUCTUATION 21 0.0019
563 BLOOD PRESSURE DECREASED 127 0.0019
564 ORAL CANDIDIASIS 25 0.0019
565 SINUSITIS 192 0.0019
566 ROTATOR CUFF SYNDROME 24 0.0019
567 HYPOMAGNESAEMIA 26 0.0019
568 NEUTROPENIA 253 0.0019
569 ORAL HERPES 36 0.0018
570 GAIT DISTURBANCE 352 0.0018
571 RASH MACULAR 64 0.0018
572 BEDRIDDEN 24 0.0018
573 LETHARGY 105 0.0018
574 SCAR 31 0.0018
575 PARAESTHESIA 283 0.0018
576 MUSCLE TIGHTNESS 29 0.0018
577 VERTIGO 109 0.0018
578 DIARRHOEA 1154 0.0018
579 GASTRIC DISORDER 61 0.0018
580 INTERSTITIAL LUNG DISEASE 86 0.0018
581 COLECTOMY 10 0.0018
582 PRURITUS 679 0.0018
583 BLOOD ALBUMIN DECREASED 14 0.0018
584 PNEUMONITIS 48 0.0018
585 CEREBRAL DISORDER 13 0.0018
586 DYSSTASIA 51 0.0017
587 MIGRAINE 166 0.0017
588 PAIN 1068 0.0017
589 EXERCISE TOLERANCE DECREASED 10 0.0017
590 DISCOMFORT 106 0.0017
591 MOUTH SWELLING 10 0.0017
592 ALOPECIA 340 0.0017
593 LIMB INJURY 47 0.0017
594 RESTLESSNESS 63 0.0017
595 THROAT IRRITATION 77 0.0017
596 UNEVALUABLE EVENT 129 0.0017
597 DEPRESSED MOOD 90 0.0017
598 POLYP 11 0.0017
599 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 16 0.0017
600 PRODUCT SIZE ISSUE 9 0.0017
601 DRY SKIN 223 0.0017
602 WRIST FRACTURE 20 0.0017
603 SCAB 19 0.0017
604 CHEILITIS 9 0.0017
605 MOUTH ULCERATION 35 0.0017
606 COLD SWEAT 29 0.0016
607 COVID-19 288 0.0016
608 CHEST DISCOMFORT 168 0.0016
609 QUALITY OF LIFE DECREASED 22 0.0016
610 TOOTH FRACTURE 18 0.0016
611 RECTAL HAEMORRHAGE 70 0.0016
612 SKIN HYPERPIGMENTATION 14 0.0016
613 MENISCUS INJURY 10 0.0016
614 VISION BLURRED 223 0.0016
615 SPINAL PAIN 19 0.0016
616 HIP FRACTURE 52 0.0016
617 INTRACRANIAL PRESSURE INCREASED 9 0.0016
618 IMPAIRED QUALITY OF LIFE 23 0.0016
619 OSTEOPOROSIS 65 0.0016
620 EYE HAEMORRHAGE 21 0.0016
621 SECOND PRIMARY MALIGNANCY 13 0.0016
622 BLOOD URIC ACID INCREASED 9 0.0016
623 OESOPHAGITIS 17 0.0016
624 BLOOD TRIGLYCERIDES INCREASED 27 0.0015
625 MUSCULOSKELETAL PAIN 80 0.0015
626 RETINAL DETACHMENT 14 0.0015
627 HEAD INJURY 48 0.0015
628 NEPHROPATHY TOXIC 17 0.0015
629 INFLAMMATION 78 0.0015
630 INTERNAL HAEMORRHAGE 17 0.0015
631 HAEMATOCHEZIA 82 0.0015
632 PRODUCT USE ISSUE 279 0.0015
633 SPINAL OSTEOARTHRITIS 13 0.0015
634 DIVERTICULITIS 41 0.0015
635 TENSION 9 0.0015
636 NEUTROPHIL COUNT INCREASED 15 0.0015
637 CENTRAL NERVOUS SYSTEM LESION 20 0.0015
638 BURNING SENSATION 102 0.0015
639 SCOLIOSIS 9 0.0015
640 VAGINAL HAEMORRHAGE 63 0.0015
641 HYPERTHYROIDISM 21 0.0014
642 GASTROINTESTINAL INFECTION 13 0.0014
643 LIVER DISORDER 64 0.0014
644 VIRAL INFECTION 48 0.0014
645 HYPOTHYROIDISM 46 0.0014
646 NERVE INJURY 16 0.0014
647 MUSCULOSKELETAL STIFFNESS 126 0.0014
648 PULMONARY OEDEMA 64 0.0014
649 EAR INFECTION 38 0.0014
650 HAEMORRHAGE 149 0.0014
651 LYMPHOMA 22 0.0014
652 THERMAL BURN 10 0.0014
653 INTERVERTEBRAL DISC DEGENERATION 13 0.0014
654 GASTROINTESTINAL INFLAMMATION 11 0.0014
655 HAEMATURIA 48 0.0014
656 LACRIMATION INCREASED 42 0.0014
657 CARDIAC MURMUR 12 0.0014
658 RASH PAPULAR 31 0.0014
659 RASH 601 0.0014
660 LIVER FUNCTION TEST ABNORMAL 40 0.0014
661 CHILLS 161 0.0014
662 INTERVERTEBRAL DISC PROTRUSION 30 0.0014
663 BLOOD BILIRUBIN INCREASED 37 0.0014
664 EYE DISORDER 45 0.0014
665 AMNESIA 89 0.0014
666 PROTEINURIA 26 0.0014
667 DEVICE RELATED INFECTION 21 0.0014
668 VISUAL IMPAIRMENT 169 0.0014
669 NEOPLASM MALIGNANT 91 0.0014
670 TRANSIENT ISCHAEMIC ATTACK 46 0.0014
671 INTENTIONAL PRODUCT MISUSE 119 0.0014
672 DENTAL CARIES 15 0.0014
673 BLOOD PRESSURE DIASTOLIC DECREASED 10 0.0014
674 POST PROCEDURAL INFECTION 11 0.0014
675 FUNGAL INFECTION 45 0.0013
676 URINARY INCONTINENCE 40 0.0013
677 BASAL CELL CARCINOMA 21 0.0013
678 HAIR TEXTURE ABNORMAL 18 0.0013
679 GALLBLADDER DISORDER 24 0.0013
680 PANIC ATTACK 49 0.0013
681 FACIAL PAIN 12 0.0013
682 MACULAR DEGENERATION 16 0.0013
683 HYPERAESTHESIA 11 0.0013
684 OCULAR DISCOMFORT 15 0.0013
685 SOMNOLENCE 269 0.0013
686 HYPOPHAGIA 34 0.0013
687 APHASIA 40 0.0013
688 URINARY RETENTION 44 0.0013
689 HYPOKINESIA 19 0.0013
690 BLOOD GLUCOSE ABNORMAL 24 0.0013
691 ASPARTATE AMINOTRANSFERASE INCREASED 69 0.0013
692 FAECES DISCOLOURED 28 0.0013
693 INFLUENZA 144 0.0013
694 BACK INJURY 14 0.0013
695 WEIGHT INCREASED 288 0.0013
696 VAGINAL DISCHARGE 13 0.0013
697 CLOSTRIDIUM DIFFICILE INFECTION 28 0.0013
698 CHOKING 25 0.0013
699 CONFUSIONAL STATE 207 0.0013
700 COLON CANCER 19 0.0013
701 SQUAMOUS CELL CARCINOMA 12 0.0013
702 BLOOD GLUCOSE DECREASED 61 0.0013
703 JOINT SWELLING 153 0.0013
704 LUNG DISORDER 62 0.0013
705 DEAFNESS 33 0.0013
706 ATRIAL FLUTTER 10 0.0013
707 VENTRICULAR EXTRASYSTOLES 13 0.0013
708 ADVERSE EVENT 115 0.0012
709 FALL 415 0.0012
710 MOOD ALTERED 34 0.0012
711 EYE INFECTION 14 0.0012
712 DEPRESSION 282 0.0012
713 KNEE ARTHROPLASTY 26 0.0012
714 MUSCLE DISORDER 10 0.0012
715 CHEST PAIN 226 0.0012
716 HAEMOPTYSIS 34 0.0012
717 APHONIA 17 0.0012
718 COLITIS 46 0.0012
719 IRRITABLE BOWEL SYNDROME 26 0.0012
720 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 86 0.0012
721 BLADDER DISORDER 12 0.0012
722 UPPER LIMB FRACTURE 24 0.0012
723 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 28 0.0012
724 EOSINOPHIL COUNT INCREASED 10 0.0012
725 PROCEDURAL PAIN 33 0.0012
726 DISTURBANCE IN ATTENTION 64 0.0012
727 MUSCLE ATROPHY 15 0.0012
728 HAEMATEMESIS 30 0.0012
729 SYNCOPE 118 0.0012
730 APPENDICITIS 11 0.0012
731 DISEASE RECURRENCE 56 0.0012
732 ANOSMIA 17 0.0012
733 ARTERIOSCLEROSIS 11 0.0012
734 FOOT FRACTURE 22 0.0012
735 ATRIAL FIBRILLATION 113 0.0012
736 NEPHROLITHIASIS 53 0.0012
737 HEPATIC FUNCTION ABNORMAL 43 0.0012
738 POST PROCEDURAL COMPLICATION 22 0.0011
739 IMMUNODEFICIENCY 17 0.0011
740 SPINAL OPERATION 14 0.0011
741 EXTRA DOSE ADMINISTERED 46 0.0011
742 INCONTINENCE 12 0.0011
743 THINKING ABNORMAL 21 0.0011
744 SINUS TACHYCARDIA 16 0.0011
745 PHOTOPHOBIA 21 0.0011
746 GOUT 20 0.0011
747 FREQUENT BOWEL MOVEMENTS 30 0.0011
748 PHARYNGITIS STREPTOCOCCAL 12 0.0011
749 HYPOKALAEMIA 51 0.0011
750 DEATH 951 0.0011
751 METASTASES TO BONE 18 0.0011
752 PAIN IN JAW 31 0.0011
753 SPEECH DISORDER 57 0.0011
754 ALANINE AMINOTRANSFERASE INCREASED 66 0.0011
755 HEPATIC STEATOSIS 20 0.0011
756 PULMONARY EMBOLISM 102 0.0011
757 MOBILITY DECREASED 77 0.0011
758 RIB FRACTURE 22 0.0011
759 PRESYNCOPE 26 0.0011
760 INTESTINAL PERFORATION 12 0.0011
761 ULCER 17 0.0011
762 SENSORY DISTURBANCE 17 0.0011
763 FRACTURE 20 0.0011
764 ARRHYTHMIA 50 0.0011
765 SPUTUM DISCOLOURED 10 0.0011
766 BRONCHITIS 78 0.0011
767 GASTRIC ULCER 20 0.0011
768 CARDIAC OPERATION 9 0.0010
769 FLUID RETENTION 53 0.0010
770 PARAESTHESIA ORAL 15 0.0010
771 PYELONEPHRITIS 9 0.0010
772 GLAUCOMA 20 0.0010
773 CHOLELITHIASIS 34 0.0010
774 INFECTION 150 0.0010
775 MANIA 17 0.0010
776 THROMBOTIC MICROANGIOPATHY 10 0.0010
777 AUTOIMMUNE DISORDER 10 0.0010
778 THERAPY INTERRUPTED 73 0.0010
779 DECREASED IMMUNE RESPONSIVENESS 10 0.0010
780 SKIN HAEMORRHAGE 15 0.0010
781 BLOOD LACTATE DEHYDROGENASE INCREASED 16 0.0010
782 PNEUMOTHORAX 16 0.0010
783 CHOLECYSTITIS 12 0.0010
784 PYREXIA 348 0.0010
785 HAEMATOMA 26 0.0010
786 POLYNEUROPATHY 12 0.0010
787 PERICARDIAL EFFUSION 23 0.0010
788 BODY TEMPERATURE INCREASED 20 0.0010
789 UROSEPSIS 9 0.0010
790 SKIN CANCER 21 0.0010
791 ERYTHEMA 199 0.0010
792 IMPAIRED DRIVING ABILITY 11 0.0010
793 DERMATITIS CONTACT 11 0.0010
794 SWELLING 90 0.0010
795 INFLUENZA LIKE ILLNESS 79 0.0010
796 DERMATITIS 20 0.0010
797 ARTHROPATHY 53 0.0010
798 EYE PRURITUS 32 0.0010
799 MENTAL IMPAIRMENT 23 0.0009
800 GAMMA-GLUTAMYLTRANSFERASE INCREASED 21 0.0009
801 ELECTROLYTE IMBALANCE 11 0.0009
802 INCORRECT DOSE ADMINISTERED 216 0.0009
803 HYPERSENSITIVITY 175 0.0009
804 MOVEMENT DISORDER 30 0.0009
805 ATELECTASIS 9 0.0009
806 NIGHTMARE 32 0.0009
807 CEREBRAL HAEMORRHAGE 33 0.0009
808 LEUKOPENIA 46 0.0009
809 LOCALISED INFECTION 22 0.0009
810 UPPER RESPIRATORY TRACT INFECTION 42 0.0009
811 HYPONATRAEMIA 51 0.0009
812 HYPOTENSION 180 0.0009
813 WOUND 25 0.0009
814 FEAR 24 0.0009
815 CARDIAC DISORDER 83 0.0009
816 HEART RATE DECREASED 31 0.0009
817 RENAL FAILURE 116 0.0009
818 BRAIN OEDEMA 11 0.0009
819 SWOLLEN TONGUE 27 0.0009
820 WEIGHT FLUCTUATION 9 0.0009
821 CARPAL TUNNEL SYNDROME 12 0.0009
822 IMPAIRED HEALING 28 0.0009
823 SKIN BURNING SENSATION 61 0.0009
824 SKIN ULCER 22 0.0009
825 PNEUMONIA 275 0.0008
826 DRUG INEFFECTIVE 1118 0.0008
827 ANKLE FRACTURE 13 0.0008
828 RASH ERYTHEMATOUS 40 0.0008
829 HALLUCINATION 63 0.0008
830 COMPLICATION ASSOCIATED WITH DEVICE 12 0.0008
831 PRODUCT PRESCRIBING ISSUE 18 0.0008
832 RESPIRATORY TRACT CONGESTION 13 0.0008
833 PAIN OF SKIN 22 0.0008
834 LIVER INJURY 20 0.0008
835 DIABETES MELLITUS 62 0.0008
836 PRODUCT TASTE ABNORMAL 11 0.0008
837 DIPLOPIA 21 0.0008
838 MALNUTRITION 9 0.0008
839 SPINAL FRACTURE 16 0.0008
840 LOSS OF CONSCIOUSNESS 102 0.0008
841 HYPOAESTHESIA ORAL 12 0.0008
842 PRODUCT PHYSICAL ISSUE 16 0.0008
843 OEDEMA 43 0.0008
844 CHOLECYSTECTOMY 9 0.0008
845 PULMONARY FIBROSIS 15 0.0008
846 OEDEMA PERIPHERAL 95 0.0008
847 SUBDURAL HAEMATOMA 11 0.0008
848 BONE DISORDER 14 0.0008
849 BLISTER 43 0.0008
850 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 13 0.0008
851 PULMONARY CONGESTION 10 0.0008
852 APATHY 11 0.0008
853 BACTERIAL INFECTION 14 0.0007
854 FEBRILE NEUTROPENIA 49 0.0007
855 MUSCLE TWITCHING 17 0.0007
856 DISORIENTATION 29 0.0007
857 TENDON RUPTURE 9 0.0007
858 ISCHAEMIC STROKE 13 0.0007
859 PHARYNGITIS 9 0.0007
860 COAGULOPATHY 12 0.0007
861 MENTAL STATUS CHANGES 20 0.0007
862 COORDINATION ABNORMAL 10 0.0007
863 DERMATITIS ALLERGIC 9 0.0007
864 CELLULITIS 36 0.0007
865 PRODUCT PRESCRIBING ERROR 17 0.0007
866 DRUG DOSE OMISSION 117 0.0007
867 SEPSIS 78 0.0007
868 RESPIRATORY TRACT INFECTION 18 0.0007
869 LOWER LIMB FRACTURE 13 0.0007
870 EYE PAIN 38 0.0007
871 ACCIDENT 8 0.0007
872 FLUSHING 68 0.0007
873 IRRITABILITY 40 0.0007
874 ANGINA PECTORIS 19 0.0007
875 INTENTIONAL PRODUCT USE ISSUE 58 0.0007
876 PALLOR 18 0.0007
877 OSTEOARTHRITIS 28 0.0007
878 SWELLING FACE 43 0.0007
879 SEIZURE 76 0.0007
880 CONJUNCTIVITIS 12 0.0006
881 OXYGEN SATURATION DECREASED 36 0.0006
882 SKIN REACTION 9 0.0006
883 PARANOIA 11 0.0006
884 PRODUCT COMPLAINT 16 0.0006
885 HYPOXIA 22 0.0006
886 HEPATIC CANCER 15 0.0006
887 EYE SWELLING 23 0.0006
888 GASTROENTERITIS 9 0.0006
889 CEREBROVASCULAR ACCIDENT 104 0.0006
890 DEMENTIA 17 0.0006
891 PRESCRIBED UNDERDOSE 12 0.0006
892 DEEP VEIN THROMBOSIS 39 0.0006
893 PRODUCT DISPENSING ERROR 13 0.0006
894 MOOD SWINGS 19 0.0006
895 MELAENA 13 0.0006
896 HEMIPARESIS 10 0.0006
897 AGITATION 43 0.0006
898 HEPATOTOXICITY 13 0.0006
899 SKIN LESION 16 0.0006
900 MUSCULOSKELETAL DISORDER 11 0.0006
901 THERAPY PARTIAL RESPONDER 9 0.0006
902 SLEEP APNOEA SYNDROME 11 0.0006
903 FIBROMYALGIA 14 0.0006
904 ORTHOSTATIC HYPOTENSION 10 0.0006
905 URTICARIA 95 0.0006
906 DYSARTHRIA 21 0.0006
907 GASTRIC CANCER 14 0.0006
908 ROAD TRAFFIC ACCIDENT 23 0.0005
909 RASH MACULO-PAPULAR 12 0.0005
910 LUNG NEOPLASM MALIGNANT 22 0.0005
911 HYPOACUSIS 23 0.0005
912 ANGER 18 0.0005
913 DELIRIUM 18 0.0005
914 THROAT TIGHTNESS 14 0.0005
915 FEMUR FRACTURE 16 0.0005
916 STAPHYLOCOCCAL INFECTION 17 0.0005
917 DRUG RESISTANCE 13 0.0005
918 ABSCESS 8 0.0005
919 HYPERGLYCAEMIA 18 0.0005
920 DYSKINESIA 20 0.0005
921 SKIN EXFOLIATION 41 0.0005
922 HYPERKALAEMIA 17 0.0005
923 LOWER RESPIRATORY TRACT INFECTION 22 0.0005
924 LIP SWELLING 16 0.0005
925 HEPATIC CIRRHOSIS 9 0.0005
926 BONE DENSITY DECREASED 15 0.0005
927 GENERAL PHYSICAL HEALTH DETERIORATION 55 0.0005
928 ACUTE MYOCARDIAL INFARCTION 14 0.0005
929 HEPATITIS 12 0.0005
930 SKIN IRRITATION 21 0.0005
931 TREATMENT NONCOMPLIANCE 25 0.0005
932 ACUTE RESPIRATORY DISTRESS SYNDROME 8 0.0005
933 TRANSAMINASES INCREASED 10 0.0004
934 CARDIAC FAILURE 36 0.0004
935 PRODUCT ADMINISTRATION ERROR 9 0.0004
936 PNEUMONIA ASPIRATION 11 0.0004
937 PSYCHOTIC DISORDER 13 0.0004
938 PRODUCT AVAILABILITY ISSUE 10 0.0004
939 MENTAL DISORDER 19 0.0004
940 HEPATIC FAILURE 13 0.0004
941 AGRANULOCYTOSIS 8 0.0004
942 ACNE 32 0.0004
943 NERVOUS SYSTEM DISORDER 13 0.0004
944 TYPE 2 DIABETES MELLITUS 14 0.0004
945 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 14 0.0004
946 CEREBRAL INFARCTION 10 0.0004
947 ASTHMA 46 0.0004
948 WHEEZING 24 0.0004
949 OCULAR HYPERAEMIA 19 0.0004
950 EYE IRRITATION 23 0.0004
951 CHRONIC KIDNEY DISEASE 30 0.0004
952 EPILEPSY 12 0.0004
953 SEPTIC SHOCK 17 0.0004
954 INTERNATIONAL NORMALISED RATIO INCREASED 11 0.0004
955 MYOCARDIAL INFARCTION 66 0.0004
956 CARDIAC FAILURE CONGESTIVE 30 0.0004
957 ECZEMA 19 0.0004
958 GASTROINTESTINAL HAEMORRHAGE 30 0.0004
959 THERAPY NON-RESPONDER 16 0.0004
960 CARDIOVASCULAR DISORDER 9 0.0004
961 BLOOD CREATINE PHOSPHOKINASE INCREASED 10 0.0003
962 ACUTE KIDNEY INJURY 53 0.0003
963 RESPIRATORY DISORDER 10 0.0003
964 C-REACTIVE PROTEIN INCREASED 12 0.0003
965 DRUG INTERACTION 52 0.0003
966 TOXICITY TO VARIOUS AGENTS 55 0.0003
967 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 17 0.0003
968 PANCREATITIS 17 0.0003
969 RENAL INJURY 9 0.0003
970 EXPIRED PRODUCT ADMINISTERED 10 0.0003
971 ACCIDENTAL OVERDOSE 11 0.0003
972 BLINDNESS 12 0.0003
973 BREAST CANCER 27 0.0003
974 RESPIRATORY FAILURE 21 0.0003
975 INJURY 18 0.0003
976 DEPRESSED LEVEL OF CONSCIOUSNESS 10 0.0003
977 ABNORMAL BEHAVIOUR 10 0.0003
978 HYPOGLYCAEMIA 12 0.0002
979 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 15 0.0002
980 PRODUCT STORAGE ERROR 18 0.0002
981 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 34 0.0002
982 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 9 0.0002
983 MEDICATION ERROR 9 0.0002
984 AGGRESSION 8 0.0002
985 RHEUMATOID ARTHRITIS 18 0.0002
986 ACCIDENTAL EXPOSURE TO PRODUCT 16 0.0002
987 SUICIDAL IDEATION 13 0.0001
988 TREATMENT FAILURE 10 0.0001
989 OVERDOSE 25 0.0001
990 PSORIASIS 15 0.0001
991 CARDIAC ARREST 9 0.0001
992 NO ADVERSE EVENT 17 0.0001
993 PRODUCT QUALITY ISSUE 12 0.0001